An important fund to finance the fight against AIDS, tuberculosis and malaria is seeking new investments worth £ 1
French President Emmanuel Macron launches the final round to replenish the Global Fund in Paris.
to be called "a decisive moment".
The fund says progress has slowed as a result of fluctuating political exposure and increased the growth of insecticides and drug resistance.
Raising the target amount could save 16 million lives is said to halve the mortality rate among these three major diseases.
The £ 11 billion ($ 14 billion) would be spent on medications that treat the transmission of HIV, tuberculosis medication and mosquito nets to protect against malaria.
"Progress Has Faltered"
The Fund's Executive Director, Peter Sands, told BBC News, "We have made extraordinary progress in reducing these deaths – but this progress has stalled."
I am really impressed by the strong political support for the Global Fund in many different capitals.
"I am not at all content with the challenge of raising the money we need – and of course the geopolitical environment is complicated.
" However, we are confident that we have a strong investment case and a demonstrable degree of effectiveness. " he said.
The Global Fund has generally been seen as a success story in the collection and use of global health funds by governments and other donors.
The investment case, however, warns of funding shortfalls, stating that this could jeopardize the third fund Sustainable Development Goal – an internationally agreed goal to end disease epidemics and create resilient health systems for all.
"New danger of infection"
Malaria cases increase after years of steady decline. Two-thirds of all malaria deaths are affected in children under five years old.
And even though millions of millions of people have died from AIDS, the massive increase in Africa's young population threatens more new infections than the epidemic at the beginning of this century.
Tuberculosis kills more people than any other infectious disease – and drug-resistant cases account for a third of all worldwide deaths due to antibiotic resistance.
The Director-General of the World Health Organization, dr. Tedros Adhanom Ghebreyesus praised the "truly impressive growth of the World Fund" in its 17 years.